Baxter's Preflucel gets EU OK

Baxter International has received the approval of a European repeat mutual recognition procedure by the Austrian Agency for Health and Food Safety for the Preflucel seasonal influenza vaccine. The 13 participating EU countries, including Germany, Spain, UK and Nordic countries, will formally implement the license on a national level to make Preflucel available for the 2011-12 influenza season. Baxter release

Suggested Articles

After years of R&D, partners Johnson & Johnson have secured European approval for their Ebola vaccine regimen.

The FDA has laid out clear efficacy requirements for a full approval, but the emergency use authorization pathway isn't so clear, an expert said.

Pfizer and its COVID-19 vaccine partner BioNTech posted positive early data for one of their four candidates in the worldwide race.